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Nonmedical Limits in Individual Life Insurance
James B. Ross* and Shalini E. Perumpral t

Abstract
This paper shows data that illustrate the substantial variation among nonmedical schedules and the dramatic increase in their amount limits from 1972
through 1992. Coefficients of variation are analyzed for several data subsets.
We find that the variation of schedules in the sample of all firms has increased
throughout the 1972-1992 period for issue ages up to 30, but has declined for
issue ages beyond 30 during the 1982-1992 period. For the non-New York and
stock companies our statistical tests indicate an increase in the variability of
schedules over the full period 1972 to 1992.
Key words and phrases: mortality, underwriting, medical examinations, schedules, coefficient of variation

Introduction
The practice of granting life insurance without a medical examination began in England when underwriting evidence consisted of personal interviews, opinions of associates and friends, and/or attending
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physicians' statements. Medical evidence began to be required in 1850,
and a medical examination was considered essential until 1885. In 1886
cautious experiments to remove the medical examination on smaller
policies began, albeit with substantial restrictions that were gradually
lifted in view of favorable results.
The rationale for nonmedicallimits 1 for insurance policies had been
that the savings in medical exam expenses were sufficient to offset the
additional mortality experienced in the absence of underwriting information from medical exams. A shortage of medical examiners in rural
areas following World War I led a group of Canadian companies to begin nonmedical programs with restrictions on issue ages and amounts.
The practice was well received in the field, the early experience was
favorable, and the Canadian program was liberalized and expanded.
Beginning in 1925 nonmedical underwriting spread rapidly through
the American life insurance industry, and by 1935 86 percent of the
129 members of the American Life Convention had adopted nonmedical programs. Today nearly every life insurer in the United States and
Canada accepts some nonmedically underwritten business, and it is estimated that 67 percent of new ordinary policies and 33 percent of new
ordinary amounts are written nonmedically (Black and Skipper, 1994,
Chapter 24, p. 671).
Because the insurer pays for medical evidence it uses in underwriting the application, there are initial expense savings when no medical
examination is required. The actuarial mechanics of the construction of
such schedules are well established: the present value over the policy
life of the excess mortality experienced under nonmedical underwriting
is equated to the expense savings at issue, and the equation is solved
for the face amount that balances it.
Nonmedical limit schedules theoretically should depend on the cost
of medical exams and the additional mortality experienced in their absence, suggesting that the schedules for different companies should
not vary much. In practice, however, variation among companies enters via differing attitudes in areas such as mortality selection standards, persistency rates, returns on investments, target markets, degrees of accommodation to the writing agent, safety/profit margins in
the premium structure, and stock versus mutual forms of insurer organization. This paper addresses questions raised by the existence of
a large number of nonmedical limit schedules that exhibit substantial
variation.
1 A nonmedical limit for a new life insurance policy is the maximum amount of insurance that can be issued without the benefit of a medical or paramedical examination.
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Changes in nonmedical limits over the last two decades have been
characterized in Black and Skipper (1994, Chapter 24, p. 672) as "nonmedical limits exploded." Great increases in nonmedical limits represent the responses by companies to large increases in the cost of medical examinations over the period of this study. Companies have dealt
with the cost increases in medical examinations by using less expensive
paramedical exams and by making cost-effective use of blood and urine
testing.
The extent to which nonmedical limit schedules vary is an empirical
question. This paper seeks to determine both the degree of the current
variation and the trend in variation over time: Is competition driving the
schedules together, or are individual company differences forcing them
apart? We show how nonmedical limits have developed, summarize the
current situation, and explore the variations of schedules of different
insurers.

2

Factors Impacting Nonmedical Limits

While this paper focuses on nonmedical limits, there is a continuum
of underwriting approaches of which medically examined business and
nonmedical business are the extremes. All variations are driven by the
trade-off between expense savings and differential mortality costs. This
dynamic trade-off is a function of the increase in the cost-effectiveness
of underwriting tools, increases in medical exam costs, and continuing improvements in insured mortality. Paramedical underwriting provides the best example (Woodman, 1992). Paramedical underwriting
has advanced to the point where separate mortality experiences are
maintained for this approach. Blood and urine testing also offer protective values that are cost-effective at levels less than full nonmedical
limits. Additionally, companies review periodically their use of other
underwriting tools such as inspection reports, attending physicians'
statements (APSs), personal health interviews (PHIs), and motor vehicle
records (MVRs). These reviews may cause companies to revise the issue
amounts at which they order such tools.
Inflation is one of the major forces that drew attention to the nonmedical area. The chairman of an extended discussion in 1970 on the
impact of inflation on underwriting remarked: "There is evidence that
the cost of medical underwriting has increased more rapidly than the
health care index, so we can conclude that the major components of
underwriting costs have increased more rapidly than the Consumer
Price Index" (Taylor 1970). The Statistical Abstracts of the United States
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Price Index
Consumer Prices
Medical Care
Physicians' Services
Average Policy Size Issued

1972-1982
131%
148%
145%
168%

1982-1992
45%
106%
94%
154%

1972-1992
236%
410%
375%
580%

provides the data for the percentage increases in related price indices
shown below for the periods 1972-1982, 1982-1992, and 1972-1992.
Data from the Life Insurance Fact Book show that the percentage increases in the average size policy issued have more than kept pace with
these inflationary increases in the several price indices.
The onset of AIDS as a significant factor in underwriting occurred
during the period 1982-1992. During this period AIDS dominated discussions of underwriting in the actuarialliterature. 2 Company responses have included blood testing at much lower face amount levels in
applicant cohorts where AIDS is a concern. Prior to 1985 blood testing
generally was not requested until face amounts applied for exceeded
$1 million. HIV/ AIDS changed that dramatically. Blood/urine/saliva
testing for HIV now begins at $25,000 to $100,000. Additionally, some
observers feel that companies may have slowed increases in nonmedical
limits and conformed their nonmedical schedules by issue ages to those
of competitors to avoid being selected against by the HIV-infected.

3 Literature Review
This literature review concentrates on papers and discussions dealing with the factors impacting nonmedical limits. Outside the actuarial
literature there is substantial additional underwriting material relevant
to this subject, particularly in the publications of the Home Office Life
Underwriters Association and the Institute of Home Office Underwriters.
2For the period up to December 31, 1991, during which information could affect
company decisions on nonmedical limits for 1992, there were several papers and task
force reports on AIDS (though not all focused on underwriting) that were published by
the Society of Actuaries. These include the Guide for Practicing Actuaries (1988), Panjer
(1989), Plumley (1989), Ramsay (1989 and 1990), the Report of the Society of Actuaries
Committee on HW Research (1990), and the Report of the Task Force on the Financial
Implications of AIDS (1990).
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The literature contains three themes. The first theme consists of historical examinations of nonmedical limits in ordinary (and industrial)
life insurance. Parker (1921) reviews the Canadian experiment. Auden
(1938) gives a brief history, an update on the practice of 114 companies,
a review of the reasons for writing nonmedical business, and a report on
the generally favorable mortality. Morton (1977) discusses nonmedical
and paramedical underwriting in his review of underwriting principles
and practices. Sankey (1990) and Black and Skipper (1994, Chapter 24,
pp. 671-672) provide historic treatments for more recent periods.
The second theme, review and liberalization, consists of a long series
of discussions in the actuarial and underwriting journals responding to
questions by editors. Smith (1924) emphasizes the early success of the
Canadian nonmedical program. Larus (1925) cautions against competition on nonmedical limits, while Parker (1925) feels that companies
doing a nonmedical business contribute meaningfully to the information maintained by the Medical Impairment Bureau.
As liberalizations develop, the discussions focus on nonmedical mortality experience relative to that of medically examined business. Smith
(1930) uses Canadian male select mortality as a benchmark; Shepherd
(1930) benchmarks against American male select mortality. Both find
the ratios of actual-to-expected mortality (AlE ratios) for nonmedical
issues higher than the ratios for medically examined business; both
find the AlE ratios for nonmedical issues in age groups beyond age 45
substantially higher than their medically examined counterparts. Smith
and Cross (1930) indicate higher lapse rates on the nonmedical issues.
Marshall (1932) provides data showing the favorable mortality experience of Connecticut Mutual. Discussions in Record of the American
Institute ofActuaries (1934) identify issue age 40 as the supportable upper age for nonmedical schedules, providing several examples at older
issue ages of substantially higher AlE ratios (relative to American male
select mortality) for nonmedical issues than for those medically examined.
Auden (1938) cites reductions from upper age 45 to age 40 as the
trend of the day, with nonmedical persistency still poor but nonmedical
mortality satisfactory. He discusses the value of the forgone expense of
the medical exam in offsetting additional mortality. Hunter (1940) inventories mortality studies (up to 1931 for three Canadian companies
and five American companies) and adds New York Ufe data through
1939 to show generally favorable nonmedical experience. Discussions
in Record of'the American Institute ofActuaries (1942) center around the
problems of obtaining medical examiners during World War II and the
nonmedical liberalizations that would help reduce the load on examin-
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ers (the consensus was "yes" to amounts, "no" to age extensions). The
increase in the percentage of applications on a nonmedical basis that accompanied nonmedical schedule liberalizations is discussed, with one
large company's percentage in 1942 going from 9 percent in July to 30
percent in October!
The central issue in Record of the American Institute of Actuaries
(1946) is wartime mortality; all commentators on nonmedical limits
come to the same general conclusion, viz. that nonmedical business
still could be written satisfactorily at issue ages under 40 for amounts
up to $5,000. The discussions in the Transactions of the Society of Actuaries (1950) indicate that the triggering incident for the announcement
of nonmedical limit increases is a specific increase in medical examiner
fees.
Merriam (1951) describes an increase in medical examiner fees of
about one-third, with resulting extensions of nonmedical limits in the
Metropolitan Life to the age groups 41-45 and 46-50. Mathews (1953)
provides survey evidence from 108 companies that such extensions
are not common-only 5 percent of the companies issue nonmedically
above age 40. Morton (1954) reports that most Canadian companies
continu'e some nonmedical issue amount to age 45, but provides discounted extra mortality costs that suggest only nominal amounts are
feasible. Van Keuren (1956) indicates that Metropolitan Life, which introduced nonmedical issues above age 40 in 1951, has discontinued
them because of unsatisfactory mortality experience and the necessity
to obtain medical exams on 25 percent of nonmedical applicants.
Jacoby and Tookey (1959) both indicate pressure from physicians to
increase the medical examination fees. They attribute this to doctors'
aversion to paper work, the lagging of fees behind price levels, and
resentment that insurers would attempt to fix doctors' fees. All discussants (Transactions of the Society of Actuaries, 1960) note increases of
$25,000 to $30,000 up to age 30, but few increases thereafter.
Lew (1966) predicts increased use of bodily fluids testing to extend
the use of nonmedical limits to older age groups. Gauer and van Keuren
(1967) explore the use of technicians and early paramedical techniques.
The difficulty of finding physicians willing to serve as medical examiners is noted. Many discussants note the use of medical information
phoned-in and recorded. Keltie (1969) attributes the slowdown in mortality improvement on medically examined business to the spread of
paramedical exams and alludes to reductions in the use of inspection
reports and attending physicians' reports.
The third theme consists of the readings gathered by the Society of
Actuaries under the rubric of cost implications in the Professional Actu-
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arial Specialty Guide to Individual Underwriting (1993). Ormsby (1963)
first examines the economics of underwriting in a paper that addresses
the considerations involved in ordering inspection reports. He provides
formulas for" ... converting changes in underwriting action attributable
to information in the APS (attending physician's statement) into equivalent 'net' single premiums at issue so that a comparison can be made
of these 'net' single premiums with the total cost of obtaining and processing the statement itself ... " The techniques outlined are applicable
to the construction of nonmedical limit schedules.
Mast (1978) discusses each element of the nonmedical limit question. His paper determines the break-even amount as "... the policy size at which the increased mortality costs resulting from the lack
of a medical examination are approximately counterbalanced by the
consequent savings in underwriting expenses." He mentions an asset
share approach, and discusses the net single premium technique used
by Ormsby: " ... the relationship between the expenses associated with
obtaining a medical examination and the present value of the increased
mortality cost per $1,000 is used to determine the break-even amount."
Reitano (1979) provides a consistent theory for evaluating the interplay between the cost of underwriting tools and the resulting mortality.
He discusses two cases:

• The actuarial approach typically used in setting nonmedical limits,
using the present value of the difference between medical and
nonmedical mortality experience (the two table technique); and
• The underwriting approach for valuing underwriting tools (as in
Ormsby), under which the value of the tool is the present value of
the extra mortality costs that are saved by remOving certain lives
from the standard issue class (the single table method).
Bergstrom (1989,1991) discusses the assumptions and calculations
that provide estimates for the protective values of blood chemistry profile and urinalysis testing. The earlier study gives protective values
for life insurance, the latter for major medical insurance. The reports
show the techniques for expressing the results in terms of amount levels above which the testing is cost-justified and in terms of return on
the investment (ROI) in the testing.
Mills (1991) provides a general model for such protective value studies, utilizing the axiom that" ... a particular underwriting procedure has
positive economic value if its cost is less than the savings in mortality
(or morbidity) made possible by its use." Mills provides an example for
valuing the attending physician's statement in connection with disability income.
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Woodman (1992) assesses the value of the paramedical examination using the tools and approach specified by Bergstrom. He provides
comparisons between medical, paramedical, and nonmedical mortality
experience; his further analysis indicates the age-at-issue groups and
amount ievels for which the several underwriting approaches are most
appropriate.

4

Data Sources

The data used in the statistical analyses are the nonmedical limit
amounts published in Best's Flitcraft Compend (Life-Health) for the editions dated 1973, 1983, and 1993. The data collection procedures used
by A.M. Best Co. are such that the data relate to the years 1972, 1982,
and 1992. It is these latter years that are used in the table headings and
the text.
The nonmedical limit information, when available, is given in the
policy analysis section (preceding the statistical sections) of the Flitcraft
Compend. The availability of nonmedical schedules is shown in Table 1,
which gives in the panel headings the number of companies contributing nonmedical limit schedules to each year of the study. The material
available for analysis grew substantially from 1972 to 1982, then shrank
in 1992 because the A.M. Best Company split the Flitcraft Compendinto
two sections, only one of which preserved the nonmedical data. As a
result there are data on 113 companies for 1972, 164 companies for
1982, and 119 companies for 1992. Forty-eight companies provided
data for all three years.
The basic data (not shown) consist of values for the nonmedical
limits across each of the 15 issue age groups for each company plus
additional values for independent variables representing specific characteristics of individual companies. The issue age groups used by different life insurers in practice are so similar that less than 20 forcings
were needed to put the nonmedical schedules into the common format
of 15 groups by age at issue.

Table 1
Characteristics of the Sample of All Firms Nonmedical Limits (OOOs)

Panel A: 1992 Sample (N = 119)
Age at Issue
0-4 5-14 15 16-1718-2021-2526-30 31-3536-4041-4546-50 51-5556-60 61-6566-70
Number of Companies*
115 115 118 118 118 118 118 118 118 115 107 52 36 18 10
Mean
222 225 224 220 208 209 209 180 140 86.6 66.3 25.4 17.5 5.50 1.63
Standard Deviation
153 155 137 138 134 134 134 99.8 89.2 65.1 65.3 53.6 50.1 18.3 7.42
Median
0
0
0
0
200 200 200 200 200 200 200 150 100 75 50
Mode
250 250 100 100 100 100 100 100 100 100 50
0
0
0
0
Maximum
1000 1000 1000 1000 1000 1000 1000 500 500 350 350 350 350 100 50
Minimum
000000000000000
Panel B: 1982 Sample (N = 164)
Age at Issue
0-4 5-14 15 16-1718-2021-2526-30 31-35 36-4041-4546-50 51-5556-60 61-6566-70
Number of Companies*
162 162 163 164 164 164 164 162 162 150 82 37 22 16 10
Mean
134 139 139 141 141 145 144 108 70.6 40.1 25.2 15.8 14.4 8.50 5.57
Standard Deviation
84.5 82.5 81.3 81.0 80.9 86.4 86.9 85.2 82.5 75.4 75.9 72.2 72.3 47.5 42.4
Median
100 100 100 100 100 100 100 75 50 20
2
0
0
0
0
Mode
0
0
0
0
0
100 100 100 100 100 100 100 100 50 25
Maximum
500 500 500 500 500 500 500 500 500 500 500 500 500 500 500
Minimum
o 0 o 15 15 25 25 0 0 0 0 0 0 0 0
Panel C: 1972 Sample (N = 113)
Age at Issue
0-4 5-14 15 16-1718-2021-2526-30 31-35 36-40 41-4546-50 51-55 56-60 61-6566-70
Number of Companies*
113 113 113 113 113 113 112 111 111 71
18
9
5
2
0
Mean
30.2 31.9 32.7 33.0 33.1 32.9 32.0 20.9 11.0 3.31 0.50 0.15 0.07 0.02 0
Standard Deviation
9.18 7.83 6.61 6.46 6.39 6.19 6.77 6.04 5.22 3.62 1.49 0.58 0.34 0.17 0
Median
30 30 30 35 35 30 30 20 10
3
0
0
0
0
0
Mode
30 30 30 30 30 30 30 20 10
5
0
0
0
0
0
Maximum
50 50 50 50 50 50 50 50 50 25 10
4 2.5 1.5 0
10 10 10 10 10
0
0
0
0
0
0
0
0
0
Minimum
5
* Number of companies with nonzero nonmedical limits
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Methodology

For each age group for each of the years 1972, 1982, and 1992 these
univariate statistics for the nonmedical limits are calculated: mean,
median, mode, maximum, minimum, and standard deviation. We also
count and display the number of companies that provide nonzero nonmedical limits to a particular age group. These characteristics are displayed in Table 1. The same statistics are provided in Table 2 for the
48 companies with data for all three years.
Because our interest is to determine the extent of current variation
among issuers and the trend in variation over time, a test for stationarity of variance seems logical. Given the tremendous increase in nonmedical limits in the decade from 1972 to 1982, however, stationarity
tests of the variance do not provide any insight as to the real divergences in behavior within the industry. Therefore, coefficients of variation are calculated for each age group for the years 1972, 1982, and
1992, and a series of nonparametric tests is performed on this statistic.
Statistical tests are used to determine: (i) whether variation within
the industry has remained consistent for the two decades-this test
was suggested in 1937 by Friedman (1991); and (ii) whether the variation has consistently increased or decreased over the two decades-this
test was suggested in 1963 by Page (1991). Appendix A describes these
tests for the entire sample, giving the null and alternative hypotheses,
the calculated coefficients of variation, formulas for the test statistics,
and the cut-off points for rejection at selected confidence levels. The
Friedman and Page tests are performed on the entire sample and repeated again for those 48 companies for which data are available for
both decades. This approach allows us to isolate any bias that may have
been introduced by outliers or new entrants into the full sample.
The 48 firms for which data are available for 1972, 1982 and 1992
are also split into stock (22) and mutual (26) companies and New York
(22) and non-New York (26) insurers. Similar tests are performed on
these samples to determine whether there are any identifiable differences in behavior among these subgroups. The stock/mutual split is
chosen to explore whether the philosophy or practices inherent in the
form of company organization may influence the nonmedical limits.
The non-New York/New York split is chosen to test whether the New
York expense and commission limitations (and perhaps the extraterritoriality) would impact the nonmedical limits.

;;0

Table 2
Characteristics of the Sample of 48 Firms Nonmedical Limits (OOOs)

Panel A: 1992 Sample (N = 48)
Age at Issue
0-4 5-14 15 16-1718-2021-2526-3031-3536-4041-4546-5051-5556-60 61-6566-70
Number of Companies*
47 47 47 48 48 48 48 47 47 47 47 21
11
6
3
Mean
253 259 261 264 252 252 252 204 149 83.5 66.4 29.1 21.5 7.04 1.63
Standard Deviation
163 167 166 163 162 162 162 105 93.4 73.9 72.9 71.9 71.8 22.3 8.00
Median
250 250 250 250 250 250 250 200 100 50 50
0
0
0
0
Mode
250 250 250 250 250 250 250 100 100 50 50
0
0
0
0
Maximum
1000 1000 1000 1000 1000 1000 1000 500 500 350 350 350 350 100 50
Minimum
o 0 0 30 30 30 30 0 0 0 0 0 0 0 0
Panel B: 1982 Sample (N =48)
Age at Issue
0-4 5-14 15 16-1718-2021-2526-3031-3536-4041-4546-5051-5556-60 61-6566-70
Number of Companies*
6
2
2
2
48 48 48 48 48 48 48 47 47 42 16
Mean
137 136 135 135 136 135 134 94.0 50.7 23.1 7.42 1.28 0.11 0.11 0.11
Standard Deviation
70.0 68.3 65.1 65.1 64.9 64.3 65.0 60.3 40.0 24.2 18.0 4.43 0.72 0.72 0.72
Median
0
0
0
0
0
100 100 100 100 125 125 120 75 50 15
Mode
0
0
0
0
0
100 100 100 100 100 100 100 100 50 10
Maximum
5
5
5
300 300 300 300 300 300 300 300 200 100 100 25
Minimum
30 30 30 30 30 30 30
0
0
0
0
0
0
0
0
Panel C: 1972 Sample (N = 48)
Age at Issue
0-4 5-14 15 16-1718-2021-2526-3031-3536-4041-4546-5051-5556-60 61-6566-70
Number of Companies*
48 48 48 48 48 48 48 47 47 27
3
2
1
1
0
Mean
29.7 31.6 32.8 33.2 33.2 33.1 32.1 19.8 9.96 2.96 0.21 0.16 0.03 0.03 0
Standard Deviation
9.31 7.52 5.92 5.60 5.60 5.61 6.09 5.62 3.43 3.20 0.92 0.69 0.22 0.22 0
Median
30 30 30 35 35 30 30 20 10
3
0
0
0
0
0
Mode
30 30 30 30 30 30 30 20 10
0
0
0
0
0
0
Maximum
50 50 50 50 50 50 50 40 25 12
5
4 1.5 1.5 0
10 10 15 20 20 20
15
0
0
0
0
0
0
0
0
Minimum
* Number of companies with nonzero nonmedical limits
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6 Analysis and Findings
Panels A, B, and C of Table 1 show the descriptive statistics for all
firms for the set of 15 age groups over 1972-1992. The data show the
stunning increases in nonmedical limits, particularly over 1972-1982.
The mean is consistently higher than the median and the mode, with few
exceptions, suggesting that some companies offer significantly larger
nonmedical limits than their competitors.
Panels A, B, and C of Table 2 show the descriptive statistics for the 48
companies. The same patterns of skewness, with the mean being higher
than the median and the mode, emerge for 1992 and 1982, while the
1972 figures emulate a normal distribution.
Table 3 shows the percentage increase in the mean nonmedical limits for the periods 1972-1982, 1982-1992, and from 1972-1992. Percentage increases for 1972-1982 are substantial in every age category,
especially beyond issue age 40. There are further increases in the mean
nonmedical limits for every issue age category in the second decade.
These increases are much smaller than those in the earlier decade but
more evenly distributed along the age range.
Table 4 shows that the percentage of companies offering nonzero
nonmedical limits at issue ages beyond age 40 has risen dramatically
since 1972. This may reflect the lower mortality rates due to improved
health care and the reduction of death rates from diseases significant to
the elderly. The percentage of companies offering nonzero nonmedical
insurance to groups below the age of 15 dropped slightly.
A comparison of the various coefficients of variation3 suggests that
the differences among companies increased over both decades for the
first seven age groups (0-30) in the total sample, particularly in the
decade from 1972 to 1982 (Table 5). For the next five age groups (3155) the variation increased from 1972 to 1982, but the differences in
nonmedical limits among companies decline markedly. For the last
three age groups the variation among companies from 1972 to 1992
consistently declined. Much of the reduction in variation at the older
ages can be attributed to those companies which went from zero to positive nonmedical limits in that age range. The data further suggest that
positive socioeconomic factors for the older age groups in the decade
from 1982 to 1992 may have overridden any differences in individual
company underwriting costs. The greater variability in practice for the
lower age groups, however, suggests that company poliCies differ more
in targeting this age group.
3The coefficient of variation is the ratio of the standard deviation to the (nonzero)
mean.
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Table 3
Percentage Increases in Mean
Non-Medical Limits: All Firms (in %)
Age Range 1972-82 1982-92 1972-92
0-4
5-14
15-15
16-17
18-20
21-25
26-30
31-35
36-40
41-45
46-50
51-55
56-60
61-65
66-70

347
336
325
327
326
344
353
417
545
1,118
4,980
10,500
21,186
42,900
00

66
62
61
56
48
43
44
67
97
115
161
60
17
(36)
(71)

640
605
585
567
528
535
553
761
1,173
2,516
13,160
16,833
24,900
27,400
00

For the entire sample the null hypothesis that variation among firms
did not change from decade to decade is rejected at the 5 percent level
using Friedman's nonparametric test (Table 6). The alternate hypothesis that the variation increased over time could neither be accepted nor
rejected using Page's ordered test, while a second alternate hypothesis
that the variation decreased over time failed to be accepted (Table 7).
The analysis suggests that the divergent pattern in nonmedical limits
for the younger age groups more than offsets the convergent patterns
for the older age groups, but only to a small extent. There is no ordered pattern to this variation, however; neither the highest nor the
lowest nonmedical limits fall in the same issue age category for the
years 1972, 1982, and 1992.
The results are similar when the tests are performed only on the 48
firms for which data are available for both decades. The null hypothesis
that variations among firms did not change from decade to decade fails
to be rejected (Table 6 and Table 7). This is true even though the pattern
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Age
Range
0-4
5-14
15-15
16-17
18-20
21-25
26-30
31-35
36-40
41-45
46-50
51-55
56-60
61-65
66-70

Table 4
Percentage of Companies Offering
Nonzero Nonmedical Privileges
Percent Increase (in %)
1972
100.0
100.0
100.0
100.0
100.0
100.0
99.1
98.2
98.2
62.8
15.9
8.0
4.4
1.7
0

1982
98.8
98.8
99.4
100.0
100.0
100.0
100.0
98.8
98.8
91.5
50.0
22.6
13.4
9.8
6.1

1992
96.6
96.6
99.2
99.2
99.2
99.2
99.2
99.2
99.2
96.6
89.9
43.7
30.3
15.1
8.4

1972-82
(1.2)
(1.2)
(0.6)
0
0
0
0.9
0.6
0.6
45.7
214.5
182.5
204.5
444.4
00

1982-92
(2.2)
(2.2)
(0.2)
(0.8)
(0.8)
(0.8)
(0.8)
0.4
0.4
5.6
79.8
93.4
126.1
54.1
37.7

1972-92
(3.4)
(3.4)
(0.8)
(0.8)
(0.8)
(0.8)
0.1
1.0
1.0
53.8
465.4
446.3
588.6
738.9
00

in the coefficient of variation for the first seven age groups shows an
increasing variation over time.
The null hypothesis fails to be rejected because there is a strong
pattern of convergence in company practices in the age groups extending from 41 to 70. The increasing similarity in the behavior of these
companies may have allowed other more independent firms to carve
niches in these target markets, which would explain the ambivalence in
the results for the entire sample.

Table 5
Coefficients of Variation for All Age Groups

Sample: All Firms
Age
0-4
5-14
15 16-17 18-20 21-25
1992
69.02 69.17 61.34 62.82 64.32 64.19
1982
63.00 59.59 58.35 57.51 57.35 59.38
1972
30.43 24.54 20.20 19.58 19.33 18.38
Sample: 48 FIrms
Age
0-4
5-14
15 16-17 18-20 21-25
1992
64.55 64.40 63.59 61.83 64.23 64.23
1982
51.29 50.33 48.15 48.15 47.65 47.54
1972
31.35 23.83 18.03 16.86 16.86 16.95
Sample: Mutual Companies - 26 Frrms
Age 0-4 5-14
15
16-17 18-20 21-25
1992
63.28 64.94 62.95 58.90 66.06 66.06
1982
44.72 45.03 45.03 45.03 45.03 74.42
1972
25.44 15.61 15.61 15.10 15.10 15.29
Sample: Stock Companies - 22 FIrms
Age 0-4 5-14
15
16-17 18-20 21-25
1992
56.21 56.21 53.23 54.73 53.23 53.23
1982
60.07 56.91 52.80 52.80 51.54 51.54
1972
36.78 32.49 21.29 19.39 19.39 19.39
Sample: New York Companies - 22 Frrms
Age
0-4
5-14
15 16-17 18-20 21-25
1992
65.02 63.02 63.02 56.59 62.48 62.48
1982
54.97 56.56 52.83 52.83 52.83 52.94
1972
23.14 17.01 17.01 17.01 17.01 17.27
Sample: Non-New York Companies - 26 Firms
Age 0-4 5-14
15
16-17 18-20 21-25
1992
49.92 49.92 48.78 51.20 52.47 52.47
1982
46.45 43.44 43.44 43.44 42.71 42.71
1972
36.00 28.82 19.14 17.09 17.09 17.09
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Table 6
The Friedman Test
Friedman Test
Statistic
Sample
6.93
All Firms
48 Firms
2.53
Mutual Companies (26)
3.63
Stock Companies (22)
19.07
New York Companies (22)
3.73
Non-New York Companies (26)
11.03
Note: Ho: tl = t2 = t3;
HI: At least one of the

Test Indication on
Null at 5% Level
Reject
Fail to reject
Fail to reject
Reject
Fail to reject
Reject

tis is different.

The 5% critical value is for this test is 5.99.

Sample
All Firms

Table 7
The Page Test
Page Test
Statistic
HI: 190
H2: 170

48 Firms

HI: 187
H2: 173

Mutual Companies (26)

HI: 188.5
H 2: 171.5

Stock Companies (22)

HI: 195

New York Companies (22)

HI: 188

H 2 : 170
H 2 : 170

Non-New York Companies (26)

HI: 196
H 2 : 164

Note: Ho: tl = t2 = t3;
HI: tl < t2 < t3;

H2: tl > t2 > t3.

The 5% critical value is for this test is 190.

Test Indication on
Null at 5% Level
Unclear
Fail to reject
Fail to reject
Fail to reject
Fail to reject
Fail to reject
Reject
Fail to reject
Fail to reject
Fail to reject
Reject
Fail to reject
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When the 48 firms are divided into New York carriers and non-New
York insurers, the statistical tests provide interesting results. The tests
indicate that the variation among New York carriers did not change
over the two decades, while the null (no change) is strongly rejected
for non-New York insurers (Table 6). Furthermore, Page's ordered test
rejects the null in favor of the alternate that the variation among firms
is increasing over time for the non-New York carriers (Table 7). The
pattern in the coefficient of variation for the New York insurers remains
similar to that for the sample of 48 firms.
When the sample of 48 firms is split on the basis of organization
into stock and mutual firms, we again find interesting differences. For
the stock companies, the null hypothesis that the variation in company
practices did not change over time is strongly rejected in favor of the
alternate (Table 6). Furthermore, Page's test rejects the null in favor
of the alternate that the variation in company practices is increasing
over time (Table 7). These variations are preponderant in the issue age
groups from 0 to 30. Although the pattern of increasingly divergent
practices exists at the lower age groups for the mutual companies, there
seems to be convergence at the higher age groups. As a result, Friedman's test fails to reject the null of no changes. This result is further
confirmed by Page's test-the null fails to be rejected in favor of either
increasing or decreasing divergence in mutual company practices over
time.

7

Conclusions

This study examines nonmedical limits for a sample of life insurance
companies over a 20 year period to determine the extent of variability in
company practices at several points in time and the change in variability
over time. The study shows a greater variability in company practices
for the lower age groups than for higher age groups. Part of this variability could be attributed to the fact that almost all companies offer
nonmedical insurance in the lower age brackets. The number of companies offering nonmedical insurance at higher age brackets decreases
sharply, particularly after age 50.
Analysis of data over time shows that the percentage of companies
offering insurance at the higher age brackets has risen while the percentage at lower age brackets has dropped slightly. The number of
companies offering nonmedical insurance to those below age 45 increased substantially in the first decade of our study, but decreased
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slightly in the second decade. There is a continuous increase, however,
in the number of firms offering nonmedical insurance at the higher age
brackets. This fact could be attributed to improved mortality rates for
the older population and to companies' increased interest in the senior
citizen market.
When the entire sample is examined, statistical tests suggest an increase in variability of company nonmedical limit schedules. When the
subs ample of 48 firms for which data are available over both decades
is examined, however, there appears to be no substantive change in the
variability of nonmedical limits. One possible explanation for these results is that new firms entering or leaving the market attempt to carve
special niches that contribute to the greater variability in nonmedical
limits.
Interesting questions about nonmedical limits in practice abound.
Do companies construct new nonmedical limit schedules analytically
along the lines suggested earlier in this paper? Or do they forego such
calculations and base their decisions in part on the schedules of other
companies-particularly competitors? How do companies manage their
agency operations with nonmedical limits less liberal than competitors?
And where is the industry headed with respect to limits for nonmedical
and paramedical acceptances and for blood/urine testing? Qualitative
data are required to provide useful answers to these questions. Perhaps
these data are best secured through a survey instrument addressed to
the companies. The survey approach would have the additional benefit of providing a larger sample by avoiding the data limitations that
a source such as the Best's Flitcraft Compend (Life-Health) necessarily
imposes.
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Appendix
The Friedman and Page statistics are explained below for the sample of all firms; for more details on these statistics see Hettmansperger
(1991). They are nonparametric tests and are performed on the coefficient of variation for the sample of all firms and for all the subsamples.
The first column of Table Al recognizes that there are 15 issue age
groups in the sample. In the remaining three columns the values of
the coefficient of variation (CV) and the respective ranking of each year
based on the CVs are provided. A value of three is given to the year
with the highest value of the CV, and the other years are rank-ordered
accordingly for each age group. The years 1972, 1982, and 1992 are
represented by tl. t2, and t3, respectively, in the tests below.
For the Friedman test, the null hypothesis and the alternative hypothesis are:
tl = t2 = t3;
At least one of the

Ho :
HI :

tiS

is different.

The test statistic is:
K*

12

k

= nk(k + 1) j~ (R.j)2
15

xl~ x 4

6.93

- 3n(k

+ 1)

x [(22)2 + (36)2 + (32)2] - 3 x 15 x 4
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Age
Group

Table Al
Coefficient of Variation
And Rank (in parentheses)
Year
1972
30.4 (1)
24.5 (1)
20.2 (1)
19.6 (1)
19.3 (1)
18.8 (1)
21.1 (1)
28.9 (1)
47.3 (1)
109.3 (2)
297.3 (2)
386.9 (2)
518.3 (3)
767.4 (3)
0.0 (1)
22

1
2
3
4
5
6
7
8
9
10
11
12
13

14
15
R·
.J

1982
63.0 (2)
59.6 (2)
58.3 (2)
57.5 (2)
57.3 (2)
59.4 (2)
60.1 (2)
78.9 (3)
116.9 (3)
188.1 (3)
300.6 (3)
457.7 (3)
501.0 (2)
558.5 (2)
762.5 (3)
36

1992
69.0 (3)
69.2 (3)
61.3 (3)
62.8 (3)
64.3 (3)
64.2 (3)
64.2 (3)
55.3 (2)
63.5 (2)
75.1 (1)
98.5 (1)
211.0 (1)
286.2 (1)
332.9 (1)
453.9 (2)
32

where k is the total number of years (k = 3); n is the number of issue
age groups (n = 15); Rij is the rank of the i-th observation in year j
relative to the other k - 1 years; and
n

R.j

=

L Rij

j

=

1,2, ... , k.

j;l

The calculated value of K* has a chi-square distribution with two
degrees of freedom. The critical values at the 5 percent and 10 percent
levels are 5.99 and 4.61, respectively. Thus, the hypothesis is rejected in
favor of the alternative that the variations in the years 1972, 1982, and
1992 are not the same. (The hypothesis, however, fails to be rejected
at the 1 percent level.)
Page's test for ordered alternatives asks whether the variable (in this
case the coefficient of variation) is increasing over time or is decreasing
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over time. The null hypothesis and the alternatives are:

tl = t2 = t3;
tl < t2 < t3;
tI>t2>t3.

Ho :
HI :

H2:
The test statistic for HI is:
k

L

Lj

x R.j

j=I

1 x 22 + 2 x 36 + 3 x 32
190.

The value of the test statistic is equal to the critical value of 190 at
the 5 percent confidence level. Therefore the hypothesis is neither accepted nor rejected in favor of the alternative HI that the coefficient of
variation is increasing over time.
The test statistic for H2 is:
k

L

L (k -

j + 1) x R.j

j=I

3 x 22 + 2 x 36 + 1 x 32
170.

Because the calculated value of 170 is less than the critical value of 190,
the hypothesis that the coefficient of variation remains constant over
time fails to be rejected.

